Clinical Trial Update: Progesterone and Second Trimester Bleeding [NA]

View source ↗

Summary

The NCT01269450 trial evaluating progesterone for second-trimester antepartum bleeding and prevention of preterm birth has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antepartum Hemorrhage
• Preterm Birth

Drugs mentioned

• PROGESTERONE (Progesterone)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Antepartum Bleeding, Preterm Birth | NA | Status: TERMINATED